Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

NCT06192875 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06192875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
September 28, 2015
Completion date
December 31, 2035
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic and lymphoid system neoplasm, malignant solid neoplasm